Clinical Features and Impact on One Year Prognosis of Prescribing Low Doses of Direct Oral Anticoagulant Agents in a Middle Eastern Population with Atrial Fibrillation: Analysis from the Jordan Atrial Fibrillation Study

Clinical Features and Impact on One Year Prognosis of Prescribing Low Doses of Direct Oral Anticoagulant Agents in a Middle Eastern Population with Atrial Fibrillation: Analysis from the Jordan Atrial Fibrillation Study

Introduction: Direct oral anticoagulant agents (DOACs) are indicated for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF). Reduced doses of DOACs are indicated in patients who have renal impairment and according to age and weight criteria. The aim of this study was to invest...

Full description

Bibliographic Details
Main Authors:	Ahmad Alayyat, Munir Zaqqa, Ayman Hammoudeh, Daria Jaarah, Mohammad Bahhour, Mohammed Nawaiseh, Imad Alhaddad
Format:	Article
Language:	English
Published:	Elsevier 2023-12-01
Series:	American Journal of Medicine Open
Subjects:	Anticoagulation Direct oral anticoagulant agents Middle East Nonvalvular atrial fibrillation Stroke Systemic embolism
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667036423000286

Similar Items

Nine‐year trend of oral anticoagulant use in patients with embolic stroke due to nonvalvular atrial fibrillation
by: Chisa Asahina, et al.
Published: (2020-10-01)

The incidence of bleeding in patients with nonvalvular atrial fibrillation using anticoagulants: a real-world report with the biggest Vietnamese data
by: Bui The Dung, et al.
Published: (2025-02-01)

A survey of reasons for continuing warfarin therapy in the era of direct oral anticoagulants in Japanese patients with atrial fibrillation: the SELECT study
by: Ikeda T, et al.
Published: (2018-01-01)

Characteristics of Japanese Patients with Nonvalvular Atrial Fibrillation on Anticoagulant Treatment: A Descriptive Analysis of J-dabigatran Surveillance and JAPAF Study
by: Yukihiro Koretsune, et al.
Published: (2019-02-01)

Incidence of cerebral microembolization in patients with nonvalvular atrial fibrillation using transcranial Doppler
by: Hamouda A.K.H El-Bahnasy, et al.
Published: (2022-01-01)

Comparative Effectiveness of Interventions for Stroke Prevention in Atrial Fibrillation: A Network Meta‐Analysis
by: Larisa G. Tereshchenko, et al.
Published: (2016-05-01)

Main factors of adherence to new oral anticoagulants and its dynamics in outpatients with nonvalvular atrial fibrillation: results of the ANTEY study
by: Yu. V. Lukina, et al.
Published: (2020-11-01)

A cross-sectional study of appropriateness evaluation of anticoagulation therapy for inpatients with nonvalvular atrial fibrillation
by: Xiao-Yuan Zheng, et al.
Published: (2023-12-01)

Newer Anticoagulants for Non-Valvular Atrial Fibrillation
by: Joseph M. Harburger, et al.
Published: (2012-05-01)

Comparison of uninterrupted anticoagulation with dabigatran etexilate or warfarin in the periprocedural period for atrial fibrillation catheter ablation: Results of the Japanese subgroup of the RE‐CIRCUIT trial
by: Yukihiko Yoshida, et al.
Published: (2018-04-01)

The Intersection of Atrial Fibrillation and Coronary Artery Disease in Middle Eastern Patients. Analysis from the Jordan Atrial Fibrillation Study
by: Ayman Hammoudeh, et al.
Published: (2024-03-01)

Traditional warfarin (Coumadin) therapy usage experience on nonvalvular atrial fibrillation before non-Vitamin K antagonists (new oral anticoagulants) era from a center in Turkey
by: Emre Ozdemir, et al.
Published: (2020-01-01)

Major determinants for the selecting antithrombotic therapies in patients with nonvalvular atrial fibrillation in Japan (JAPAF study)
by: Koichi Kusakawa, et al.
Published: (2017-04-01)

Prevalence of oral anticoagulation in atrial fibrillation
by: Eduardo Bartholomay, et al.
Published: (2014-09-01)

Health-related quality of life in nonvalvular atrial fibrillation patients with controlled or uncontrolled anticoagulation status
by: José Felipe Varona, et al.
Published: (2020-12-01)

Microembolic signal detection in patients with atrial fibrillation treated with oral anticoagulant
by: Alessandro d'Alessandro, et al.
Published: (2021-01-01)

Impact of anticoagulants, antiplatelet agents, and oral antidiabetic drugs on the risk of stroke in patients with diabetes and nonvalvular atrial fibrillation: A case-referent study
by: Lamiae Grimaldi, et al.
Published: (2024-06-01)

ANTICOAGULATION CONTROL AMONG PATIENTS WITH ATRIAL FIBRILLATION
by: Amer Rauf, et al.
Published: (2020-12-01)

Postmarketing surveillance on clinical use of edoxaban in patients with nonvalvular atrial fibrillation (ETNA‐AF‐Japan): Three‐month interim analysis results
by: Takeshi Yamashita, et al.
Published: (2019-02-01)

Prescribing Trends of Oral Anticoagulants in US Patients With Cirrhosis and Nonvalvular Atrial Fibrillation
by: Tracey G. Simon, et al.
Published: (2023-02-01)

Clinical implications of recent trials on anticoagulation in patients with atrial fibrillation
by: Arash Arya, et al.
Published: (2012-01-01)

Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2020-05-01)

Comparison of Direct Oral Anticoagulant Use for the Treatment of Non-Valvular Atrial Fibrillation in Pivotal Clinical Trials vs. the Real-World Setting: A Population-Based Study from Southern Italy
by: Ylenia Ingrasciotta, et al.
Published: (2021-03-01)

Whether Warfarin Therapy is Associated with Damage on Renal Function in Chinese Patients with Nonvalvular Atrial Fibrillation
by: Yu Kong, et al.
Published: (2016-01-01)

Secondary Precipitants of Atrial Fibrillation and Anticoagulation Therapy
by: Darae Ko, et al.
Published: (2021-11-01)

Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease
by: I. S. Daabul, et al.
Published: (2016-11-01)

Type 2 diabetes mellitus and nonvalvular atrial fibrillation in Mexico: national registries raise a red flag
by: Manlio F. Márquez-Murillo, et al.
Published: (2023-10-01)

Modern Anticoagulant Therapy for Atrial Fibrillation: Patient Adherence in Clinical Practice
by: Yu. P. Skirdenko, et al.
Published: (2022-03-01)

Effects of uninterrupted dabigatran on the intensity of anticoagulation during atrial fibrillation ablation
by: Takumi Osawa, et al.
Published: (2022-02-01)

Oral anticoagulant therapy for older patients with atrial fibrillation
by: Mario Bo, et al.
Published: (2017-09-01)

Oral Anticoagulants in Patients with Atrial Fibrillation and Active Cancer
by: Li-Ying Yu, et al.
Published: (2022-06-01)

Efficacy and safety of rivaroxaban in prevention and therapy of thromboembolic events in patients with nonvalvular atrial fibrillation
by: Tamara Kovačević Preradovic, et al.
Published: (2023-01-01)

Do all patients with atrial fibrillation need long-term anticoagulation?
by: Munish Sharma, et al.
Published: (2017-07-01)

Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation
by: Wesley T. O'Neal, et al.
Published: (2018-03-01)

Trend of Prevalence of Atrial Fibrillation and use of Oral Anticoagulation Therapy in Patients With Atrial Fibrillation in South Korea (2002–2013)
by: Mi Kyoung Son, et al.
Published: (2018-02-01)

Anticoagulant Prescribing for Non‐Valvular Atrial Fibrillation in the Veterans Health Administration
by: Adam J. Rose, et al.
Published: (2019-09-01)

New Insights into Anticoagulation in Atrial Fibrillation
by: Xiaohan Fan, MD, et al.
Published: (2011-01-01)

Stability of High‐Quality Warfarin Anticoagulation in a Community‐Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
by: Liane O. Dallalzadeh, et al.
Published: (2016-07-01)

Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation
by: Sabine F. B. van der Horst, et al.
Published: (2023-07-01)

ATRIAL FIBRILLATION IN PATIENTS WITH HEMORRHAGIC STROKE: APPROACHES TO ANTICOAGULANT THERAPY
by: A. M. Kulagina, et al.
Published: (2017-05-01)